Answers are grounded in this paper and cite their sources.
Real-world study demonstrates that telitacicept improves eGFR outcomes in IgA nephropathy, suggesting better treatment options.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Hosotani et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: